Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nanki, Toshihiro
ARRIA, NCT06611696: Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis	Not yet recruiting	4	160	Japan	Avacopan, prednisolone and rituximab, Prednisolone and rituximab	Chiba University, Kissei Pharmaceutical Co., Ltd., International University of Health and Welfare	ANCA Associated Vasculitis (AAV)	03/27	09/28
NCT05814159: A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)	Active, not recruiting	3	15	Japan	Anakinra, Kineret, Placebo	Swedish Orphan Biovitrum, CMIC Co, Ltd. Japan	Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset	12/25	06/26
BEconneCTD-ILD, NCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease	Recruiting	3	440	Europe, Japan, US, RoW	Belimumab, BENLYSTA, GSK1550188, Placebo	GlaxoSmithKline	Lung Diseases, Interstitial	10/28	12/28